Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies
- 5 February 2010
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 21 (6) , 847-851
- https://doi.org/10.1007/s10552-010-9511-z
Abstract
Background Data on long-term intra-individual variability in high-sensitivity C-reactive protein (hsCRP) are needed to determine whether one measurement adequately reflects usual levels in prospective studies of on the etiology of cancer and other chronic diseases; when not reflective, the ability to statistically detect modest to moderate associations is reduced. The authors estimated the size of this source of variability and consequent attenuation of the relative risk (RR). Methods High-sensitivity C-reactive protein (hsCRP) concentration was measured using a high-sensitivity immunoturbidometric assay in sera collected at years 2, 4, and 6 from 50 men in the placebo arm of the Prostate Cancer Prevention Trial (PCPT). After natural logarithm-transformation of hsCRP, analysis of variance was used to estimate the within- and between-individual variances from which the intra-class correlation coefficient (ICC) was calculated. Results The observed RR due to an ICC < 1 was calculated by e(ln true RR*ICC) for a range of true RRs. The 4-year ICC was 0.66. Measuring hsCRP once and assuming no other error, if the true RRs were 1.50, 2.00, and 3.00 when comparing high with low concentration, then the observed RRs would be 1.31, 1.58, and 2.06, respectively. Conclusion Investigators planning to measure hsCRP only once should design adequately sized studies to preserve inferences for hypothesized modest to moderate RRs.Keywords
This publication has 23 references indexed in Scilit:
- Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER StudyClinical Chemistry, 2009
- C-Reactive Protein Concentrations Are Very High and More Stable over Time Than the Traditional Vascular Risk Factors Total Cholesterol and Systolic Blood Pressure in an Australian Aboriginal CohortClinical Chemistry, 2009
- C‐reactive protein and colorectal cancer risk: A systematic review of prospective studiesInternational Journal of Cancer, 2008
- Intra-individual Variation of Plasma Adipokine Levels and Utility of Single Measurement of These Biomarkers in Population-Based StudiesCancer Epidemiology, Biomarkers & Prevention, 2007
- C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable PatientsJournal of the American College of Cardiology, 2006
- Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohortsBiomarkers, 2006
- Intra-Individual Variability of High-Sensitivity C-Reactive Protein Age-Related Variation Over Time in Japanese SubjectsCirculation Journal, 2006
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Five-Year Intra-Individual Variability in C-Reactive Protein Levels in a Japanese Population-Based StudyJapanese Circulation Journal, 2000
- Interindividual and Intraindividual Variability in Plasma Fibrinogen, TPA Antigen, PAI Activity, and CRP in Healthy, Young Volunteers and Patients With Angina PectorisArteriosclerosis, Thrombosis, and Vascular Biology, 1996